Literature DB >> 23787798

The surgical management of early-stage cervical cancer.

Sabina R Salicrú1, Javier F V de la Torre, Antonio Gil-Moreno.   

Abstract

PURPOSE OF REVIEW: The main objective is to update the literature data in the last year which may support a surgical approach to early cervical cancer [ECC; Stage International Federation of Gynecology and Obstetrics (FIGO) IA-IB1-IIA1]. Radical hysterectomy remains the gold standard by most international guidelines because surgical treatment has hardly changed in recent decades, except for stage IA1. RECENT
FINDINGS: Trends in clinical research in the past 12-18 months involve minimal invasive surgery (with laparoscopic surgery or robotic-assisted surgery), fertility preservation (in the initial stages and in the absence of bad prognostic factors), nerve-sparing and sentinel node techniques. Some institutions have published studies in specific groups such as older, obese or pregnant women.
SUMMARY: There is a growing trend to practice less aggressive surgery in order to preserve fertility in young women and avoid an excess of treatment in some selected patients. Therefore, nerve-sparing techniques can help to improve the quality of life. More studies are needed to demonstrate oncologic results of the sentinel node technique. Laparoscopic and robotic-assisted surgery can substitute open surgical treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23787798     DOI: 10.1097/GCO.0b013e3283630d6a

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  8 in total

1.  BRIP1 inhibits the tumorigenic properties of cervical cancer by regulating RhoA GTPase activity.

Authors:  Wei Zou; Xiangdong Ma; Wei Hua; Biliang Chen; Yanhong Huang; Detang Wang; Guoqing Cai
Journal:  Oncol Lett       Date:  2015-11-24       Impact factor: 2.967

Review 2.  Fertility-sparing management in cervical cancer: balancing oncologic outcomes with reproductive success.

Authors:  Karla Willows; Genevieve Lennox; Allan Covens
Journal:  Gynecol Oncol Res Pract       Date:  2016-10-21

3.  FPR1 mediates the tumorigenicity of human cervical cancer cells.

Authors:  Guangming Cao; Zhenyu Zhang
Journal:  Cancer Manag Res       Date:  2018-11-16       Impact factor: 3.989

4.  Nerve-sparing versus non-nerve-sparing radical hysterectomy: surgical and long-term oncological outcomes.

Authors:  Antonio Gil-Moreno; Melchor Carbonell-Socias; Sabina Salicrú; Melissa Bradbury; Ángel García; Ramona Vergés; Oriol Puig Puig; José Luís Sánchez-Iglesias; Silvia Cabrera-Díaz; Javier de la Torre; Natalia R Gómez-Hidalgo; Assumpció Pérez-Benavente; Berta Díaz-Feijoo
Journal:  Oncotarget       Date:  2019-07-16

5.  Step-wise Technical Description of Performing Ureteric Tunnel Dissection in Laparoscopic Radical Hysterectomy.

Authors:  Dipak Limbachiya; Rashmi Kumari
Journal:  Gynecol Minim Invasive Ther       Date:  2021-11-05

6.  Tailoring Pelvic Lymphadenectomy for Patients with Stage IA2, IB1, and IIA1 Uterine Cervical Cancer.

Authors:  Juan Zhou; Jing Ran; Zhen-Yu He; Song Quan; Qiong-Hua Chen; San-Gang Wu; Jia-Yuan Sun
Journal:  J Cancer       Date:  2015-02-25       Impact factor: 4.207

7.  Evolution of radical hysterectomy for cervical cancer along the last two decades: single institution experience.

Authors:  Claudia Arispe; Ana Isabel Pomares; Javier De Santiago; Ignacio Zapardiel
Journal:  Chin J Cancer Res       Date:  2016-04       Impact factor: 5.087

8.  S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism.

Authors:  Chuchu Zhao; Ermei Lu; Xiaoli Hu; Huihui Cheng; Jian-An Zhang; Xueqiong Zhu
Journal:  Cancer Manag Res       Date:  2018-09-20       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.